Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

1.2K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
1.2K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

37.9K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.9K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

926
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
926
Liver Physiology01:30

Liver Physiology

4.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratification.

Hepatology communications·2026
Same author

Socioeconomic disparities in paediatric high-powered magnet exposures epidemiology and outcomes.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2026
Same author

Ustekinumab is safe and effective in pediatric patients with Crohn's disease.

Journal of pediatric gastroenterology and nutrition·2025
Same author

Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings.

Pediatric obesity·2024
Same author

Patient perspective on exercise practices, preferences, and barriers in pediatric nonalcoholic fatty liver disease: A multicenter survey.

JPGN reports·2024
Same author

Warning Labels and High-Powered Magnet Exposures.

Pediatrics·2022

Related Experiment Video

Updated: Apr 13, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K

Nonalcoholic fatty liver disease.

Steven Fusillo1, Bryan Rudolph2

  • 1Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY.

Pediatrics in Review
|May 3, 2015
PubMed
Summary

Nonalcoholic fatty liver disease (NAFLD) is common in children, often asymptomatic. Early identification and treatment are critical, with weight loss being the most effective intervention for this growing liver condition.

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.1K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

8.0K

Related Experiment Videos

Last Updated: Apr 13, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.1K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

8.0K

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Metabolic Disorders

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in children, posing a significant public health challenge.
  • The disease often presents asymptomatically, complicating early diagnosis, with overweight and obese children being the primary demographic at risk.
  • Progression from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis underscores the urgency for timely identification and intervention.

Purpose of the Study:

  • To review the diagnostic challenges and current management strategies for nonalcoholic fatty liver disease (NAFLD) in pediatric populations.
  • To highlight the importance of early detection and effective treatment protocols for children at risk of NAFLD.
  • To discuss emerging diagnostic tools and therapeutic options for pediatric NAFLD.

Main Methods:

  • Review of current research and clinical consensus on NAFLD diagnosis and management in children.
  • Analysis of the utility and limitations of serum liver tests, particularly ALT levels, for NAFLD screening.
  • Evaluation of liver biopsy as a diagnostic gold standard versus noninvasive modalities.

Main Results:

  • Serum ALT elevation (girls: 22 U/L, boys: 25 U/L) warrants further investigation in overweight/obese children.
  • Liver biopsy remains the gold standard but is invasive; noninvasive methods require further validation in pediatric cohorts.
  • Weight loss is the most effective treatment; Vitamin E may be considered for biopsy-proven cases, with ongoing research into novel therapies.

Conclusions:

  • Early identification of NAFLD in children is crucial, especially in overweight and obese populations.
  • While serum ALT is a useful screening marker, noninvasive diagnostic tools are needed for broader application.
  • Weight management is the cornerstone of NAFLD treatment in children, complemented by potential pharmacological interventions.